Hypomethylation of the HTR1A promoter region and high expression of HTR1A in the peripheral blood lymphocytes of patients with systemic lupus erythematosus

Lupus

Volumn 20, Issue 7, 2011, Pages 678-689

  Xu, J ^a   Zhang, G L ^b   Cheng, Y Q ^a,c   Chen, B ^b   Dong, Y ^c   Li, L Q ^a   Xu, L ^a,b   Xu, X F ^c   Lu, Z P ^a   Wen, J F ^b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

depression; DNA methylation; HTR1A gene promoter region; SLE

Indexed keywords

MESSENGER RNA; SEROTONIN 1A RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DNA METHYLATION; EPIGENETICS; FEMALE; GENETIC REGULATION; HUMAN; HYPOTHESIS; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; HISTONES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTES; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RECEPTOR, SEROTONIN, 5-HT1A; RNA, MESSENGER; YOUNG ADULT;

EID: 79957615493     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203310394892     Document Type: Article

References (60)

1. Peters AH, Schubeler D. Methylation of histones: playing memory with DNA. Curr Opin Cell Biol. 2005 ; 17: 230-238 (Pubitemid 40380949)
2. Januchowski R, Prokop J, Jagodzinski PP. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J Appl Genet. 2004 ; 45: 237-248 (Pubitemid 38834576)
3. Pan Y, Sawalha AH. Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Transl Res. 2009 ; 153: 4-10
4. Strickland FM, Richardson BC. Epigenetics in human autoimmunity. Epigenetics in autoimmunity-DNA methylation in systemic lupus erythematosus and beyond. Autoimmunity. 2008 ; 41: 278-286
5. Sawalha AH, Jeffries M, Webb R, et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun. 2008 ; 9: 368-378 (Pubitemid 351791493)
6. Gorelik G, Richardson B. Aberrant T cell ERK pathway signaling and chromatin structure in lupus. Autoimmun Rev. 2009 ; 8: 196-198
7. Deng C, Lu Q, Zhang Z, et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum. 2003 ; 48: 746-756 (Pubitemid 36302012)
8. Sawalha AH, Jeffries M. Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus-prone mice. Eur J Immunol. 2007 ; 37: 1407-1413 (Pubitemid 46925323)
9. Yung RL, Quddus J, Chrisp CE, Johnson KJ, Richardson BC. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol. 1995 ; 154: 3025-3035
10. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008 ; 358: 929-939 (Pubitemid 351397092)
11. Gaipl US, Munoz LE, Grossmayer G, et al. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun. 2007 ; 28: 114-121 (Pubitemid 46680499)
12. Omdal R, Husby G, Mellgren SI. Mental health status in systemic lupus erythematosus. Scand J Rheumatol. 1995 ; 24: 142-145
13. Ishikura R, Morimoto N, Tanaka K, et al. Factors associated with anxiety, depression and suicide ideation in female outpatients with SLE in Japan. Clin Rheumatol. 2001 ; 20: 394-400 (Pubitemid 33130473)
14. Hay EM, Black D, Huddy A, et al. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum. 1992 ; 35: 411-416
15. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001 ; 57: 496-500 (Pubitemid 32757599)
16. Nery FG, Borba EF, Hatch JP, Soares JC, Bonfa E, Neto FL. Major depressive disorder and disease activity in systemic lupus erythematosus. Compr Psychiatry. 2007 ; 48: 14-19 (Pubitemid 44826975)
17. Gao HX, Campbell SR, Cui MH, et al. Depression is an early disease manifestation in lupus-prone MRL/lpr mice. J Neuroimmunol. 2009 ; 207: 45-56
18. Jackson JC, Cross RJ, Walker RF, Markesbery WR, Brooks WH, Roszman TL. Influence of serotonin on the immune response. Immunology. 1985 ; 54: 505-512 (Pubitemid 15132707)
19. Pellegrino TC, Bayer BM. Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release. Neuroimmunomodulation. 2000 ; 8: 179-187 (Pubitemid 32225752)
20. Hellstrand K, Hermodsson S. Enhancement of human natural killer cell cytotoxicity by serotonin: role of non-T/CD16+ NK cells, accessory monocytes, and 5-HT1A receptors. Cell Immunol. 1990 ; 127: 199-214 (Pubitemid 20119676)
21. Eugen-Olsen J, Afzelius P, Andresen L, et al. Serotonin modulates immune function in T cells from HIV-seropositive subjects. Clin Immunol Immunopathol. 1997 ; 84: 115-121 (Pubitemid 27353461)
22. Iken K, Chheng S, Fargin A, Goulet AC, Kouassi E. Serotonin upregulates mitogen-stimulated B lymphocyte proliferation through 5-HT1A receptors. Cell Immunol. 1995 ; 163: 1-9
23. Whitaker-Azmitia PM, Druse M, Walker P, Lauder JM. Serotonin as a developmental signal. Behav Brain Res. 1996 ; 73: 19-29 (Pubitemid 26008758)
24. Savitz J, Lucki I, Drevets WC. 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol. 2009 ; 88: 17-31
25. Aune TM, Golden HW, McGrath KM. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. J Immunol. 1994 ; 153: 489-498 (Pubitemid 24206278)
26. Aune TM, McGrath KM, Sarr T, Bombara MP, Kelley KA. Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. J Immunol. 1993 ; 151: 1175-1183 (Pubitemid 23219253)
27. Meyerhoff J, Dorsch CA. Decreased platelet serotonin levels in systemic lupus erythematosus. Arthritis Rheum. 1981 ; 24: 1495-1500 (Pubitemid 12253279)
28. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
29. Gladman DD, Urowitz MB, Goldsmith CH, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 809-813 (Pubitemid 27199995)
30. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
31. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
32. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-55.
33. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 ; 12: 189-198
34. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971 ; 9: 97-113
35. Noble PB, Cutts JH. Separation of blood leukocytes by Ficoll gradient. Can Vet J. 1967 ; 8: 110-111
36. Kaneda M, Okano M, Hata K, et al. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature. 2004 ; 429: 900-903 (Pubitemid 38843304)
37. Ehrich M, Zoll S, Sur S, van den Boom D. A new method for accurate assessment of DNA quality after bisulfite treatment. Nucleic Acids Res. 2007 ; 35: e29 - e29
38. Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A. 1992 ; 89: 1827-1831
39. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 1994 ; 22: 2990-2997 (Pubitemid 24260626)
40. Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res. 2001 ; 29: E65 - E65
41. Parbtani A, Frampton G, Yewdall V, Kasai N, Cameron JS. Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus. Clin Nephrol. 1980 ; 14: 164-172 (Pubitemid 10004462)
42. Laberge S, Cruikshank WW, Beer DJ, Center DM. Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro. J Immunol. 1996 ; 156: 310-315
43. Stefulj J, Cicin-Sain L, Schauenstein K, Jernej B. Serotonin and immune response: effect of the amine on in vitro proliferation of rat lymphocytes. Neuroimmunomodulation. 2001 ; 9: 103-108 (Pubitemid 32830599)
44. Ferriere F, Khan NA, Troutaud D, Deschaux P. Serotonin modulation of lymphocyte proliferation via 5-HT1A receptors in rainbow trout (Oncorhynchus mykiss). Dev Comp Immunol. 1996 ; 20: 273-283 (Pubitemid 26374334)
45. Sempere T, Cedeno N, Urbina M, Lima L. 8-[3H]-hydroxy-2-(di-n- propylamino)tetralin binding sites in blood lymphocytes of rats and the modulation by mitogens and immobilization. J Neuroimmunol. 2003 ; 138: 8-16 (Pubitemid 36566412)
46. Matsuda H, Ushio H, Geba GP, Askenase PW. Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies. J Immunol. 1997 ; 158: 2891-2897 (Pubitemid 127470550)
47. Stefulj J, Jernej B, Cicin-Sain L, Rinner I, Schauenstein K. mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav Immun. 2000 ; 14: 219-224 (Pubitemid 32280876)
48. Cloez-Tayarani I, Kayyali US, Fanburg BL, Cavaillon JM. 5-HT activates ERK MAP kinase in cultured-human peripheral blood mononuclear cells via 5-HT1A receptors. Life Sci. 2004 ; 76: 429-443 (Pubitemid 39458311)
49. Marazziti D, Palego L, Dal Canto B, et al. Presence of serotonin1A (5-HT1A) receptor mRNA without binding of [3H]-8-OH-DPAT in peripheral blood mononuclear cells. Life Sci. 1995 ; 57: 2197-2203
50. Lee DY, Hayes JJ, Pruss D, Wolffe AP. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell. 1993 ; 72: 73-84 (Pubitemid 23029694)
51. Hassig CA, Tong JK, Fleischer TC, et al. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc Natl Acad Sci U S A. 1998 ; 95: 3519-3524 (Pubitemid 28173160)
52. Bruns A, Blass S, Hausdorf G, Burmester GR, Hiepe F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum. 2000 ; 43: 2307-2315
53. Amoura Z, Koutouzov S, Piette JC. The role of nucleosomes in lupus. Curr Opin Rheumatol. 2000 ; 12: 369-373
54. Hu N, Long H, Zhao M, Yin H, Lu Q. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice. Scand J Rheumatol. 2009 ; 38: 464-471
55. van Bavel CC, Dieker J, Muller S, et al. Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies. Mol Immunol. 2009 ; 47: 511-516
56. Dieker JW, Fransen JH, van Bavel CC, et al. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum. 2007 ; 56: 1921-1933 (Pubitemid 47110391)
57. Geiman TM, Robertson KD. Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?. J Cell Biochem. 2002 ; 87: 117-125
58. Cervoni N, Szyf M. Demethylase activity is directed by histone acetylation. J Biol Chem. 2001 ; 276: 40778-40787
59. Wekking EM. Psychiatric symptoms in systemic lupus erythematosus: an update. Psychosom Med. 1993 ; 55: 219-228 (Pubitemid 23093013)
60. Zhou FC, Patel TD, Swartz D, Xu Y, Kelley MR. Production and characterization of an anti-serotonin 1A receptor antibody which detects functional 5-HT1A binding sites. Brain Res. 1999 ; 69: 186-201 (Pubitemid 29253811)